MOMONIE Confidentiality and Investor Review Agreement

Disclosing party: Noor Sow, founder of MOMONIE. MOMONIE’s corporate formation pathway is under review; this agreement does not represent that a separate legal entity has been formed.

1. Purpose

Confidential information is provided solely to evaluate a potential investment, advisory, strategic or commercial relationship concerning MOMONIE.

2. Confidential information

Confidential information includes non-public product, technology, security, financial, commercial, market, operating, intellectual-property and transaction materials made available in the confidential room, whether marked confidential or reasonably understood to be confidential.

3. Recipient obligations

The recipient will use the information only for the stated purpose, protect it with reasonable care, and disclose it only to professional advisers or representatives who need to know it and are bound by comparable confidentiality duties. The recipient will not reproduce, distribute, reverse engineer or use the information competitively.

4. Exclusions

Obligations do not apply to information the recipient can demonstrate was lawfully known without restriction, becomes public without breach, is received lawfully from a third party, or is independently developed without use of the confidential information.

5. Required disclosure

If disclosure is legally required, the recipient will, where permitted, provide prompt notice and disclose only what is required.

6. No license, obligation or reliance

No intellectual-property license is granted and neither party is required to enter a transaction. MOMONIE is pre-revenue. Projections and forward-looking statements are preliminary assumptions, not guarantees. Recipients must conduct their own diligence.

7. Return or deletion

On request, the recipient will return or delete confidential materials, except for archival copies required by law or routine backup systems, which remain protected.

8. Term and remedies

These duties continue for three years after acceptance; trade secrets remain protected for as long as they qualify as trade secrets. Unauthorized disclosure may cause irreparable harm for which equitable relief may be available in addition to other remedies.

9. Entire agreement

This electronic agreement is the complete confidentiality agreement for this review unless replaced by a later written agreement signed by both parties. Acceptance is recorded with the recipient’s name, version and server timestamp.